vs
Amarin Corp plc（AMRN）与Eventbrite, Inc.（EB）财务数据对比。点击上方公司名可切换其他公司
Eventbrite, Inc.的季度营收约是Amarin Corp plc的1.6倍（$73.5M vs $45.1M），Eventbrite, Inc.净利率更高（-11.1% vs -23.3%，领先12.2%），Amarin Corp plc同比增速更快（7.0% vs -3.9%），过去两年Eventbrite, Inc.的营收复合增速更高（-7.7% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
Eventbrite是源自美国的线下活动服务平台，为用户提供活动浏览、创建与推广服务，支持主办方免费在平台发布不限规模、不限数量的各类活动，是全球范围内活跃度较高的活动交易与推广平台。
AMRN vs EB — 直观对比
营收规模更大
EB
是对方的1.6倍
$45.1M
营收增速更快
AMRN
高出10.9%
-3.9%
净利率更高
EB
高出12.2%
-23.3%
两年增速更快
EB
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $73.5M |
| 净利润 | $-10.5M | $-8.2M |
| 毛利率 | — | 68.1% |
| 营业利润率 | 35.5% | -12.4% |
| 净利率 | -23.3% | -11.1% |
| 营收同比 | 7.0% | -3.9% |
| 净利润同比 | 33.0% | 2.5% |
| 每股收益（稀释后） | — | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNEB
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $73.5M | ||
| Q3 25 | $49.7M | $71.7M | ||
| Q2 25 | $72.7M | $72.8M | ||
| Q1 25 | $42.0M | $73.8M | ||
| Q4 24 | $62.3M | $76.5M | ||
| Q3 24 | $42.3M | $77.8M | ||
| Q2 24 | $67.5M | $84.6M |
净利润AMRNEB
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-8.2M | ||
| Q3 25 | $-7.7M | $6.4M | ||
| Q2 25 | $-14.1M | $-2.1M | ||
| Q1 25 | $-15.7M | $-6.6M | ||
| Q4 24 | $-48.6M | $-8.4M | ||
| Q3 24 | $-25.1M | $-3.8M | ||
| Q2 24 | $1.5M | $1.1M |
毛利率AMRNEB
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 68.1% | ||
| Q3 25 | 44.7% | 67.9% | ||
| Q2 25 | 69.2% | 67.5% | ||
| Q1 25 | 59.8% | 66.9% | ||
| Q4 24 | -15.4% | 68.2% | ||
| Q3 24 | 38.5% | 68.5% | ||
| Q2 24 | 63.4% | 70.9% |
营业利润率AMRNEB
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | -12.4% | ||
| Q3 25 | -22.4% | -1.3% | ||
| Q2 25 | -22.0% | -8.7% | ||
| Q1 25 | -39.9% | -13.2% | ||
| Q4 24 | -84.3% | -10.2% | ||
| Q3 24 | -59.5% | -11.5% | ||
| Q2 24 | -0.8% | -7.6% |
净利率AMRNEB
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -11.1% | ||
| Q3 25 | -15.6% | 8.9% | ||
| Q2 25 | -19.4% | -2.9% | ||
| Q1 25 | -37.4% | -9.0% | ||
| Q4 24 | -78.0% | -11.0% | ||
| Q3 24 | -59.4% | -4.8% | ||
| Q2 24 | 2.3% | 1.3% |
每股收益（稀释后）AMRNEB
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $-0.08 | ||
| Q3 25 | $-0.02 | $0.06 | ||
| Q2 25 | $-0.03 | $-0.02 | ||
| Q1 25 | $-0.04 | $-0.07 | ||
| Q4 24 | $-0.12 | $-0.09 | ||
| Q3 24 | $-0.06 | $-0.04 | ||
| Q2 24 | $0.00 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $299.9M |
| 总债务越低越好 | — | $144.4M |
| 股东权益账面价值 | — | $179.1M |
| 总资产 | $645.8M | $647.2M |
| 负债/权益比越低杠杆越低 | — | 0.81× |
8季度趋势，按日历期对齐
现金及短期投资AMRNEB
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $299.9M | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $298.7M | — | ||
| Q1 25 | $281.8M | — | ||
| Q4 24 | $294.2M | $441.5M | ||
| Q3 24 | $305.7M | $24.7M | ||
| Q2 24 | $306.7M | $56.7M |
总债务AMRNEB
| Q1 26 | — | — | ||
| Q4 25 | — | $144.4M | ||
| Q3 25 | — | $174.9M | ||
| Q2 25 | — | $241.3M | ||
| Q1 25 | — | $241.0M | ||
| Q4 24 | — | $240.7M | ||
| Q3 24 | — | $240.4M | ||
| Q2 24 | — | $358.7M |
股东权益AMRNEB
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $179.1M | ||
| Q3 25 | $458.9M | $189.1M | ||
| Q2 25 | $464.9M | $177.2M | ||
| Q1 25 | $473.7M | $173.3M | ||
| Q4 24 | $486.2M | $170.2M | ||
| Q3 24 | $531.4M | $179.8M | ||
| Q2 24 | $551.9M | $176.2M |
总资产AMRNEB
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $647.2M | ||
| Q3 25 | $659.8M | $744.6M | ||
| Q2 25 | $670.1M | $784.1M | ||
| Q1 25 | $655.7M | $812.3M | ||
| Q4 24 | $685.3M | $752.3M | ||
| Q3 24 | $750.6M | $817.4M | ||
| Q2 24 | $799.9M | $894.5M |
负债/权益比AMRNEB
| Q1 26 | — | — | ||
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.92× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 1.39× | ||
| Q4 24 | — | 1.41× | ||
| Q3 24 | — | 1.34× | ||
| Q2 24 | — | 2.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-60.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-60.9M |
| 自由现金流率自由现金流/营收 | — | -82.8% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $17.6M |
8季度趋势，按日历期对齐
经营现金流AMRNEB
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $-60.8M | ||
| Q3 25 | $-12.7M | $36.7M | ||
| Q2 25 | $16.6M | $-17.5M | ||
| Q1 25 | $-12.5M | $59.4M | ||
| Q4 24 | $-13.3M | $-45.3M | ||
| Q3 24 | $-2.4M | $44.6M | ||
| Q2 24 | $-2.7M | $-32.3M |
自由现金流AMRNEB
| Q1 26 | — | — | ||
| Q4 25 | — | $-60.9M | ||
| Q3 25 | — | $36.6M | ||
| Q2 25 | — | $-17.5M | ||
| Q1 25 | — | $59.4M | ||
| Q4 24 | — | $-45.3M | ||
| Q3 24 | — | $44.4M | ||
| Q2 24 | — | $-32.4M |
自由现金流率AMRNEB
| Q1 26 | — | — | ||
| Q4 25 | — | -82.8% | ||
| Q3 25 | — | 51.1% | ||
| Q2 25 | — | -24.1% | ||
| Q1 25 | — | 80.4% | ||
| Q4 24 | — | -59.2% | ||
| Q3 24 | — | 57.1% | ||
| Q2 24 | — | -38.3% |
资本支出强度AMRNEB
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% |
现金转化率AMRNEB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 5.76× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.81× | -30.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
EB
| US | $52.0M | 71% |
| Other | $21.6M | 29% |
